Greater Glasgow and Clyde Medicines

Latest Medicines Updates & News

Community Pharmacy Update: Aug 2017

Posted: Thursday, September 14, 2017

Category - Medicines Update Community Pharmacy

The latest Community Pharmacy Update bulletin can be found here. It contains items on:

  • Making the Most of My Medicines (MMy)
  • Pharmaceutical Waste
  • Seasonal Flu Vaccination
  • Pseudoephedrine and Ephedrine
  • Achieving Excellance in Pharmaceutical Care
  • Opportunity to help develop mobile app
  • SPSP
  • ONS

Published 14/09/17

Read More...

Formulary Update (August 2017)

Posted: Monday, September 4, 2017

Category - Formulary Update

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.

Read More...

MUE 06: Oral NSAIDs - An Update

Posted: Friday, August 25, 2017

Category - Medicines Update Extra

 

 Oral NSAIDs - An Update

** This bulletin supersedes PostScript Extra No. 24 **

  • There is considerable variation in individual response and tolerance to NSAIDs, but little difference in anti-inflammatory activity.
  • All NSAIDs should be avoided if possible in patients with a history of vascular disease, a high risk of cardiovascular disease (CVD), or gastrointestinal (GI) risk factors.
  • Treatment choice depends on individual response, risk factors and adverse effects, particularly GI and cardiovascular (CV) complications.
  • The lowest effective dose to control the patient’s symptoms, for the shortest duration possible, should be used. The use of ‘as required’ NSAIDs should be considered where appropriate.
  • The preferred non-selective NSAIDs are ibuprofen or naproxen. A proton pump inhibitor (PPI) may be required depending on GI risk.


Read More...